Clinical Trials Logo

Clinical Trial Summary

To evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism (PE). The use of the device will be assessed in a real-world population, with eligibility criteria that closely approximate its use in clinical practice. Up to 300 additional patients with anticoagulation treatment as the initial planned primary treatment strategy for intermediate risk PE will also be evaluated (US only).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03761173
Study type Observational [Patient Registry]
Source Inari Medical
Contact
Status Active, not recruiting
Phase
Start date December 15, 2018
Completion date October 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04795167 - FLowTriever for Acute Massive Pulmonary Embolism (FLAME)
Withdrawn NCT03027167 - Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty Phase 4
Not yet recruiting NCT05992168 - Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME) N/A